Seeking Lions: An Afternoon with Kenneth Bonert
By ACA |
https://www.youtube.com/watch?v=WxmuLnpzDFs
Read More MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study
By ACA |
Associations between the Mediterranean-DASH diet Intervention for Neurological Delay (MIND) diet and incidence of cognitive impairment have not been evaluated ...
Read More Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer’s disease preceding the disease pathology and cognitive decline
By ACA |
The present work aims to evaluate the significance of sleep disturbance and electroencephalogram (EEG) alteration in the early stage of ...
Read More Staging biomarkers in preclinical autosomal dominant Alzheimer’s disease by estimated years to symptom onset
By ACA |
Staging preclinical Alzheimer disease (AD) by the expected years to symptom onset (EYO) in autosomal dominant AD (ADAD) through biomarker ...
Read More Hospitalization, surgery, and incident dementia
By ACA |
We evaluated whether hospitalization with or without surgery increases risk for dementia or Alzheimer's disease.
Read More 2019 Alzheimer’s disease facts and figures
By ACA |
This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and ...
Read More Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer’s disease spectrum
By ACA |
We investigated relations between amyloid-β (Aβ) status, apolipoprotein E (APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng), ...
Read More The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer’s disease
By ACA |
Little is known about the role of age on neurodegeneration and protein deposition in atypical variants of Alzheimer's disease (AD).
Read More A randomized clinical trial to evaluate home-based assessment of people over 75 years old
By ACA |
There is an unmet need for effective methods for conducting dementia prevention trials.
Read More